Oryzon Genomics SA (ORY) — Tangible Net Worth Ratio
Oryzon Genomics SA (ORY) has a Tangible Net Worth Ratio of 7.3% as of December 2025. This metric is calculated by deducting intangible assets (€109.22 Million) from net assets (€117.85 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Oryzon Genomics SA shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Oryzon Genomics SA Tangible Net Worth Ratio (2011–2025)
This chart shows how Oryzon Genomics SA's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 7.3%, reflecting net assets of €117.85 Million with intangible assets of €109.22 Million EUR. Also explore ORY year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Oryzon Genomics SA (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Oryzon Genomics SA from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Oryzon Genomics SA stock valuation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 7.3% | €117.85 Million | €109.22 Million | €144.52 Million | ▲ +18.9 pp |
| 2024 | -11.5% | €87.04 Million | €97.10 Million | €108.72 Million | ▼ -111.1 pp |
| 2023 | 99.5% | €81.77 Million | €381.30K | €106.90 Million | ▲ +104.0 pp |
| 2022 | -4.5% | €72.57 Million | €75.84 Million | €103.70 Million | ▼ -20.0 pp |
| 2021 | 15.4% | €71.26 Million | €60.25 Million | €95.38 Million | ▼ -19.7 pp |
| 2020 | 35.2% | €75.93 Million | €49.22 Million | €94.11 Million | ▼ -14.9 pp |
| 2019 | 50.1% | €80.02 Million | €39.94 Million | €80.09 Million | ▲ +15.1 pp |
| 2018 | 35.0% | €45.13 Million | €29.33 Million | €67.45 Million | ▲ +0.2 pp |
| 2017 | 34.8% | €34.43 Million | €22.46 Million | €61.04 Million | ▲ +17.5 pp |
| 2016 | 17.2% | €22.73 Million | €18.81 Million | €49.74 Million | ▼ -82.7 pp |
| 2015 | 99.9% | €27.59 Million | €18.76K | €40.73 Million | ▲ +0.2 pp |
| 2014 | 99.8% | €13.89 Million | €32.00K | €26.06 Million | ▲ +0.6 pp |
| 2013 | 99.1% | €14.73 Million | €127.00K | €28.76 Million | ▲ +0.3 pp |
| 2012 | 98.8% | €16.43 Million | €191.00K | €28.78 Million | ▲ +0.3 pp |
| 2011 | 98.5% | €16.76 Million | €248.00K | €29.21 Million | — |